RG
STOK icon

Redmile Group’s Stoke Therapeutics STOK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$49.7M Sell
4,375,931
-110,050
-2% -$1.25M 5.29% 4
2025
Q1
$29.8M Sell
4,485,981
-107,648
-2% -$716K 2.82% 12
2024
Q4
$50.7M Sell
4,593,629
-119,880
-3% -$1.32M 3.53% 8
2024
Q3
$57.9M Sell
4,713,509
-7,545
-0.2% -$92.7K 3.41% 7
2024
Q2
$63.8M Sell
4,721,054
-351,995
-7% -$4.76M 3.86% 4
2024
Q1
$68.5M Buy
5,073,049
+2,447,543
+93% +$33M 2.51% 10
2023
Q4
$13.8M Sell
2,625,506
-1,247,190
-32% -$6.56M 0.49% 46
2023
Q3
$15.3M Sell
3,872,696
-82,492
-2% -$325K 0.73% 33
2023
Q2
$42M Sell
3,955,188
-190,208
-5% -$2.02M 1.61% 20
2023
Q1
$34.5M Buy
4,145,396
+3,502,966
+545% +$29.2M 1.5% 23
2022
Q4
$5.93M Sell
642,430
-193,400
-23% -$1.79M 0.24% 51
2022
Q3
$10.7M Sell
835,830
-1,157,438
-58% -$14.9M 0.42% 50
2022
Q2
$26.3M Sell
1,993,268
-31,100
-2% -$411K 1.01% 28
2022
Q1
$42.6M Sell
2,024,368
-222,300
-10% -$4.68M 1.33% 20
2021
Q4
$53.9M Sell
2,246,668
-135,290
-6% -$3.25M 1.23% 24
2021
Q3
$60.6M Sell
2,381,958
-76,600
-3% -$1.95M 1.06% 32
2021
Q2
$82.8M Sell
2,458,558
-85,504
-3% -$2.88M 1.22% 28
2021
Q1
$98.8M Sell
2,544,062
-142,172
-5% -$5.52M 1.39% 23
2020
Q4
$166M Buy
2,686,234
+136,728
+5% +$8.47M 2.01% 14
2020
Q3
$85.4M Buy
2,549,506
+47,200
+2% +$1.58M 1.57% 20
2020
Q2
$59.6M Buy
2,502,306
+336,368
+16% +$8.02M 1.1% 27
2020
Q1
$49.6M Buy
2,165,938
+1,145,160
+112% +$26.2M 1.39% 24
2019
Q4
$28.9M Buy
1,020,778
+3,300
+0.3% +$93.5K 0.69% 39
2019
Q3
$21.9M Sell
1,017,478
-4,330
-0.4% -$93.1K 0.73% 42
2019
Q2
$29.8M Buy
+1,021,808
New +$29.8M 0.84% 38